Trulicity (dulaglutide) is a prescription GLP-1 receptor agonist manufactured by Eli Lilly and approved to help manage type 2 diabetes
Results of the SOUL trial reinforce the clinical profile of the semaglutide molecule, which has been studied across a variety of therapeutic areas
Real Results You Can See and Feel Medical weight loss supports gradual, measurable progress that becomes more visible over time
At certain doses, Mounjaro has been shown to be able to induce a loss of 21% of body weight, results almost as significant as that of bariatric surgery
Russo A, Paret C, Alt F, Burhenne J, Fresnais M, Wagner W, et al
ARTICLE INFORMATION Acknowledgments Medical writing support for the development of this article, under the direction of the authors, was provided by Ian C